financetom
Business
financetom
/
Business
/
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
Jun 14, 2024 3:14 PM

June 14 (Reuters) - The U.S Senate Committee on Health,

Education, Labor, and Pensions said on Friday that Novo Nordisk

CEO Lars Jorgensen has agreed to testify voluntarily

in a September hearing focusing on U.S. prices for weight loss

drugs Ozempic and Wegovy.

(Reporting by Puyaan Singh in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved